Risk of Delayed Lymph Node Metastasis in Clinically N0 Esthesioneuroblastoma

Abstract

Objective To determine both the rate of delayed cervical lymph node metastasis in patients with esthesioneuroblastoma (ENB) and a clinically N0 untreated neck and the effectiveness of salvage treatment.

Design Retrospective review.

Setting Tertiary academic medical center.

Participants All patients from January 1, 1965, to December 31, 2010, who received definitive treatment for ENB.

Main Outcome Measures The study involved 52 patients: 27 (52%) patients underwent surgery and adjuvant radiotherapy (SART) to the primary site only and 25 (48%) underwent surgery alone (SA) as treatment of the primary site, without elective neck dissection.

Results Median follow-up for the SART group was 10 years versus 15.7 years for the SA group. The 10-year delayed cervical lymph node metastasis estimate is 41%. With median follow-up of 47 months after salvage treatment, the 4-year cervical lymph node recurrence-free survival estimate is 70%; the 5-year overall survival estimate is 39%.

Conclusions Delayed cervical lymph node metastases are common, indolent, and salvaged effectively in most patients. We propose that patients with ENB and clinically N0 cervical lymph nodes may choose to forego elective neck dissection or elective neck radiotherapy in favor of neck observation within their initial treatment.

Keywords

cervical lymph node metastasis - esthesioneuroblastoma - radiotherapy - surgery

• References

• 1 Ow TJ, Bell D, Kupferman ME, Demonte F, Hanna EY. Esthesioneuroblastoma. Neurosurg Clin N Am 2013; 24 (1) 51-65
• 2 Eden BV, Debo RF, Larner JM , et al. Esthesioneuroblastoma. Long-term outcome and patterns of failure—the University of Virginia experience. Cancer 1994; 73 (10) 2556-2562
• 3 Elkon D, Hightower SI, Lim ML, Cantrell RW, Constable WC. Esthesioneuroblastoma. Cancer 1979; 44 (3) 1087-1094
• 4 Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM. Esthesioneuroblastoma: prognosis and management. Neurosurgery 1993; 32 (5) 706-714 , discussion 714–715
• 5 Faragalla H, Weinreb I. Olfactory neuroblastoma: a review and update. Adv Anat Pathol 2009; 16 (5) 322-331
• 6 Zanation AM, Ferlito A, Rinaldo A , et al. When, how and why to treat the neck in patients with esthesioneuroblastoma: a review. Eur Arch Otorhinolaryngol 2010; 267 (11) 1667-1671
• 7 Bruno P, Varman A, Avellaneda G , et al. Management of esthesioneuroblastoma: past, present and future. Biohelikon: Cancer Clin Res. 2014; 2 (2) 1-5
• 8 Foote RL, Morita A, Ebersold MJ , et al. Esthesioneuroblastoma: the role of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 1993; 27 (4) 835-842
• 9 Spaulding CA, Kranyak MS, Constable WC, Stewart FM. Esthesioneuroblastoma: a comparison of two treatment eras. Int J Radiat Oncol Biol Phys 1988; 15 (3) 581-590
• 10 König MS, Osnes T, Meling TR. Treatment of esthesioneuroblastomas. Neurochirurgie 2014; 60 (4) 151-157
• 11 Beitler JJ, Fass DE, Brenner HA , et al. Esthesioneuroblastoma: is there a role for elective neck treatment?. Head Neck 1991; 13 (4) 321-326
• 12 Demiroz C, Gutfeld O, Aboziada M, Brown D, Marentette LJ, Eisbruch A. Esthesioneuroblastoma: is there a need for elective neck treatment?. Int J Radiat Oncol Biol Phys 2011; 81 (4) e255-e261
• 13 Davis RE, Weissler MC. Esthesioneuroblastoma and neck metastasis. Head Neck 1992; 14 (6) 477-482
• 14 Noh OK, Lee SW, Yoon SM , et al. Radiotherapy for esthesioneuroblastoma: is elective nodal irradiation warranted in the multimodality treatment approach?. Int J Radiat Oncol Biol Phys 2011; 79 (2) 443-449
• 15 Monroe AT, Hinerman RW, Amdur RJ, Morris CG, Mendenhall WM. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation. Head Neck 2003; 25 (7) 529-534
• 16 Kadish S, Goodman M, Wang CC. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 1976; 37 (3) 1571-1576
• 17 Levine PA, McLean WC, Cantrell RW. Esthesioneuroblastoma: the University of Virginia experience 1960-1985. Laryngoscope 1986; 96 (7) 742-746
• 18 Bachar G, Goldstein DP, Shah M , et al. Esthesioneuroblastoma: The Princess Margaret Hospital experience. Head Neck 2008; 30 (12) 1607-1614
• 19 Dulguerov P, Allal AS, Calcaterra TC. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol 2001; 2 (11) 683-690
• 20 Gore MR, Zanation AM. Salvage treatment of late neck metastasis in esthesioneuroblastoma: a meta-analysis. Arch Otolaryngol Head Neck Surg 2009; 135 (10) 1030-1034
• 21 Dias FL, Sa GM, Lima RA , et al. Patterns of failure and outcome in esthesioneuroblastoma. Arch Otolaryngol Head Neck Surg 2003; 129 (11) 1186-1192